biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	14AAFC77-0643-4788-B119-F83BB6867BA7
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A115-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A115-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A115-01A
biospecimen__bio__biospecimen_barcode_bottom	0108433557
biospecimen__bio__day_of_creation	16
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	11
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-DD-A115.C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	G
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.20
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2010
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A115
biospecimen__shared__patient_id	A115
clinical__ablation__ablation_performed_indicator	YES
clinical__ablation__ablation_type	Other
clinical__ablation__ablation_type_other	alcohol ablation
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A115-A42009
clinical__ablation__bcr_ablation_uuid	78525079-E6FC-4EFF-9561-63014E747D02
clinical__ablation__days_to_ablation_performed	855
clinical__ablation__days_to_embolization_performed	1121
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_therapy_drug_name	Doxorubicin
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	chemoembolic mixture
clinical__ablation__treatment_cycles_count	1
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	576D2562-B176-4B81-BB19-BAC808B48B96
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.1
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.6
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.1
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.1
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	10
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Alcohol consumption
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	Smoking
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	1.0
clinical__chol_lihc_shared__specimen_collection_method_name	Extended Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	53
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A115-F38780
clinical__clin_shared__bcr_followup_uuid	6D6B8B11-0E91-402C-8665-65BDC1A5738E
clinical__clin_shared__day_of_form_completion	9
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__measure_of_response	Stable Disease
clinical__clin_shared__month_of_form_completion	4
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	337
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2012
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2002
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	YES
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	469
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__rx__bcr_drug_barcode	TCGA-DD-A115-D42008
clinical__rx__bcr_drug_uuid	3E81299F-E306-4CB2-910E-62C3C022D4A4
clinical__rx__clinical_trail_drug_classification	Phase II
clinical__rx__days_to_drug_therapy_end	841
clinical__rx__days_to_drug_therapy_start	502
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T3
clinical__shared_stage__system_version	5th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	4d68ffc7-a194-4b0f-8edb-6608486ccaf0
gdc__aliquots__concentration	0.16
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A115-01A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	7fb915c7-e6b4-4909-a0bf-f5cc5f3f44c5
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.84
gdc__analytes__analyte_id	f84aed93-d9db-4491-a6db-d5b6d6f1422b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	45b566d7-f120-471c-a94a-be7936889f2d
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	80481ba2-cad9-5415-b92d-327c0c6b2429
gdc__demographic__ethnicity	not reported
gdc__demographic__gender	male
gdc__demographic__race	white
gdc__demographic__year_of_birth	1949
gdc__demographic__year_of_death	2008
gdc__diagnoses__age_at_diagnosis	19697
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-19697.0
gdc__diagnoses__days_to_death	2542.0
gdc__diagnoses__diagnosis_id	5e7ef6f5-7360-5baf-a65b-3a6792b13368
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	27.990362811791382
gdc__exposures__exposure_id	8a87d87f-c86b-5329-9951-114c9cefe2f7
gdc__exposures__height	168.0
gdc__exposures__weight	79.0
gdc__file_id	272ab114-d1bf-4197-961a-d51e66181b55
gdc__file_name	236884e8-0123-42cd-a95e-651d8c5b21c9.mirbase21.mirnas.quantification.txt
gdc__file_size	50436
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	f45971d23fadc11992191bfef8214b2c
gdc__portions__is_ffpe	false
gdc__portions__portion_id	c66517e5-b11d-4244-8027-3b84402b2dfd
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	3198
gdc__samples__initial_weight	230.0
gdc__samples__oct_embedded	false
gdc__samples__pathology_report_uuid	C0EAB9A6-AAA3-48D5-AE3F-A428D828D63C
gdc__samples__sample_id	670ffb57-959a-496a-bd9f-d04f71b0c357
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	1.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	3.0
gdc__slides__percent_stromal_cells	7.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	BOTTOM
gdc__slides__slide_id	0839a9e5-5b00-4722-9b9a-04ea65382018
gdc__submitter_id	mirna_swap_dr11_374_MirnaExpressionbe335207-36d8-4cc7-bcfb-cdaa320f857b_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	bddd0c26-e678-5b1f-91a8-25b3315aaa09
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:23.728+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4d68ffc7-a194-4b0f-8edb-6608486ccaf0-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/4d68ffc7-a194-4b0f-8edb-6608486ccaf0-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129807
manually_curated__local_md5	7996138d3cbef1ecac6ef59065e9cce5
manually_curated__opengdc_download_date	2018-10-16T17:12:11.000520+02:00
manually_curated__opengdc_file_md5	7027737c7ed09267584ab94829774e3f
manually_curated__opengdc_file_size	50435
manually_curated__opengdc_id	4d68ffc7-a194-4b0f-8edb-6608486ccaf0-meq
manually_curated__origin_file_size	129807
manually_curated__origin_last_modified_date	Tue Oct 16 17:55:00 CEST 2018
manually_curated__origin_md5	7996138d3cbef1ecac6ef59065e9cce5
manually_curated__tissue_status	tumoral
